These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10265096)

  • 1. A comparison of pharmaceutical manufacturers as a source of drug information to a telephone inquiry: generic vs brand.
    Generali JA; Hogan L
    Drug Inf J; 1983; 17(3):195-204. PubMed ID: 10265096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness to physicians' requests for information concerning drug interactions: a comparison of brand and generic companies.
    Thomas M; Lexchin J
    Soc Sci Med; 1990; 31(2):153-7. PubMed ID: 2389150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Information provided by generic and brand-name pharmaceutical manufacturers in response to a request.
    Fernandez-Llimos F; Vazquez Gomez I
    Pharm World Sci; 2007 Dec; 29(6):683-7. PubMed ID: 17464571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opinions regarding the Academy of Managed Care Pharmacy dossier submission guidelines: results of a small survey of managed care organizations and pharmaceutical manufacturers.
    Nichol MB; Knight TK; Epstein J; Honda DH; Tretiak R
    J Manag Care Pharm; 2007 May; 13(4):360-71. PubMed ID: 17506602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. News media coverage of medication research: reporting pharmaceutical company funding and use of generic medication names.
    Hochman M; Hochman S; Bor D; McCormick D
    JAMA; 2008 Oct; 300(13):1544-50. PubMed ID: 18827211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early achievements of the Danish pharmaceutical industry-7].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2014; (42):31-62. PubMed ID: 25816561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informational content of official pharmaceutical industry web sites about treatments for erectile dysfunction.
    Waack KE; Ernst ME; Graber MA
    Ann Pharmacother; 2004 Dec; 38(12):2029-34. PubMed ID: 15507499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Objective evaluation of generic-specific drug information].
    Iijima H; Koshimizu T; Shiragami M
    Yakugaku Zasshi; 2007 Mar; 127(3):541-5. PubMed ID: 17329940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites.
    Tyrawski J; DeAndrea DC
    J Med Internet Res; 2015 Jun; 17(6):e130. PubMed ID: 26032738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the accuracy of citations in drug promotional brochures.
    Keng A; Coley RM
    Ann Pharmacother; 1994 Nov; 28(11):1231-5. PubMed ID: 7849333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMCP Format dossier requests: manufacturer response and formulary implications for one large health plan.
    Spooner JJ; Gandhi PK; Connelly SB
    J Manag Care Pharm; 2007; 13(1):37-43. PubMed ID: 17269835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the gluten content of nonprescription drugs: information for patients with celiac disease.
    Mangione RA; Patel PN; Shin E; Fiebert J
    J Am Pharm Assoc (2003); 2011; 51(6):734-7. PubMed ID: 22068195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription for fairness: a new approach to tort liability of brand-name and generic drug manufacturers.
    Rostron A
    Duke Law J; 2011 Feb; 60(5):1123-91. PubMed ID: 21365961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Objective evaluation of generic drug information.
    Iijima H; Kamei M; Koshimizu T; Shiragami M
    Yakugaku Zasshi; 2004 Jun; 124(6):341-7. PubMed ID: 15170069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfite content of drug products.
    Dalton-Bunnow MF
    Am J Hosp Pharm; 1985 Oct; 42(10):2196-201. PubMed ID: 4061462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generics market in Greece: the pharmaceutical industry's beliefs.
    Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
    Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Activities of Representatives of Companies-Manufacturers of Pharmaceuticals Related to Informing Specialists with Purpose of Efficient Application of Medications].
    Kudriashova AI; Orlova EV; Rostova NB
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2018 Jul; 26(4):230-235. PubMed ID: 30365274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Three types of brand name loyalty strategies set up by drug manufacturers].
    PréMont MC; Gagnon MA
    Healthc Policy; 2014 Nov; 10(2):79-89. PubMed ID: 25617517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.